phase. We postulate that, based on the very close morphological interrelation between the uterus and the ovary, the β-HCG of the endometrium is the primary factor for the maintenance of the corpus luteum and early pregnancy.
Introduction
A close morphological and functional interrelation exists between the uterus and ovaries, with both organs interconnected by a network of lymph and blood vessels. The physiological regulation of a fertile reproductive cycle in mammals depends on interaction between hypothalamus-pituitary, ovarian and uterine stimuli. Over the past 20 years, much has been learned about the interrelation between the affluent and effluent lymph and vascular drainage in and around both ovarian and uterine tissues, the blood and lymphatic vessels around these tissues responding to the steroid milieu. Changes in utero-ovarian blood flow are important to luteal function during the menstrual cycle and in early pregnancy. Luteal maintenance may be mediated by the local vascular transport of luteotrophic or anti-luteolytic substances from the gravid uterus to the ovary (Mapletoft et al., 1976; Del Campo et al., 1980) . In this respect it is of particular interest to elucidate those factors that affect the development, maintenance and regression of the corpus luteum and the role of the uterus which, in early pregnancy in mammals, has a profound effect on luteal function (Anderson and Musah, 1989) .
Many morphological findings sustain the theory of a utero-ovarian interaction. Some authors have reported on the existence of a counter-current exchange mechanism between the blood vessels of the human uterine adnexae. Isotopically labelled progesterone, when infused into the uterine cavity, was detected after a short time in the ovary. Likewise, progesterone infused into the uterine vein was found immediately in the ipsilateral ovary via a local arteriovenous transfer (Bendz et al., 1979; Halket et al., 1985; Einer Jensen et al., 1989) During the secretory phase an increased circulation of the endometrium is observed which is the result of an intensive blood flow and a forced vascularization that includes the lymph vessels. The ovarian blood flow is highest during the luteal phase, though a marked uterine blood flow is also seen during the secretory phase. Luteal maintenance may be mediated by local vascular transport of luteotrophic or anti-luteolytic substances from the gravid uterus to the ovary. The follicle is free of lymph drainage, but the corpus luteum is rich in lymph vessels (Morris and Sass, 1966) . In the endometrium, during the luteal phase, lymph vessels grow up to the glandular epithelium; thus, it appears that in this phase both morphological and functional changes occur (Reiffenstuhl, 1957) .
Few data are available in women regarding the influence of the uterus on luteal function. Until now, it has been believed that the uterus does not affect the ovulatory cycle. Knobil (1973 Knobil ( , 1974 reported an uninterrupted ovarian function after hysterectomy in rhesus monkey. Continuation of ovarian cycles indicates no dependence on uterine luteolytic stimuli, but luteotrophic stimulation by the uterus is not excluded. In mammals, a luteolytic influence on the corpus luteum is mostly evident. In those animals (e.g. guinea pig, ewe, sow, heifer) which are influenced by luteolysis, hysterectomy interrupts periodicity, whereas in animals with a uterine luteotrophic stimulation of the corpus luteum (e.g. dog, squirrel, ferret, rhesus monkey, human), it does not abolish the ovarian cycle. The human secretory endometrium produces and secretes many substances, including hormones [prolactin (PRL), prostaglandin E, oxytocin, etc.], cytokines [interleukin (IL)-1, IL-6, tumour necrosis factor-alpha (TNF-α), etc.] (Laird et al., 1994) and growth factors [epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), etc.] which show luteotrophic effects both in vivo and in vitro. Until now, luteinizing hormone (LH) has remained the only luteotrophic hormone identified during the menstrual cycle, though a possible role of PRL remains unsubstantiated.
Luteal maintenance soon after conception depends on human chorionic gonadotrophin (HCG) stimulation. HCG is regarded mainly as a pregnancy-specific hormone, although it was detected in certain epithelial tissues and tumours (Braunstein et al., 1979; Marcillac et al., 1992) β-HCG was also found in lymphocytes (Harbour-McMenamin et al., 1986) and has been shown to have a luteotrophic influence on the ovary bearing the corpus luteum. HCG rescues the corpus luteum and stimulates progesterone production necessary for decidualization. Therefore, we postulated that the glandular epithelium of the endometrium produces and secretes HCG which can reach the corpus luteum via several morphological interrelations.
Localization of HCG in endometrial tissue sections Human subjects and tissue fixation
Normal endometrial tissue specimens were obtained during diagnostic curettages carried out during a cancer prevention programme. The age of the subjects ranged from 20 to 38 years and in all the cases the phase of the menstrual cycle was dated histologically (proliferative, n = 15, early secretory, n = 7; mid secretory, n = 5; late secretory, n = 3). The tissues were fixed routinely in 70% ethanol for 12 h, 4% paraformaldehyde in 0.1 M phosphate buffer (PB) pH 7.4, for a further 12 h and then paraffin-embedded. Subsequently, sections of 8-12 µm thickness were deparaffinized in xylene, dehydrated in descending ethanol concentrations and washed in 0.1 M Tris-buffered saline (TBS) pH 7.4, at room temperature. Chemicals were purchased from DAKO, Hamburg, Germany; Merck, Darmstadt, Germany; Pharmacia Biotech, Freiburg, Germany; Sigma, Munich Germany; NEN, Köln, Germany; Fluka, Munich, Germany; BoehringerMannheim, Mannheim, Germany and J.T.Baker.
Immunochemistry
The endogenous peroxidase activity of tissue sections was quenched by 0.6% hydrogen peroxide in TBS for 30 min. The sections were washed three times for 1 min in TBS, preincubated with 3% normal goat serum in TBS (NGS-TBS) for 30 min and subsequently incubated with an anti-β-HCG antiserum (1:200 in NGS-TBS) for 24 h at 4°C. The β-HCG antiserum (polyclonal, rabbit antihuman) was obtained from DAKO. Cross-reactivity with LH was reported to be about 3% (Metha and MacDonald, 1982) . The sections were re-washed three times over a 10 min period in TBS and incubated with biotinylated goat anti-rabbit immunoglobulin G (6 mg/ml TBS containing 2% bovine serum albumin; TBS-BSA) for 60 min, and further incubated for 1 h with a streptavidin-biotin-per-oxidase complex in TBS-BSA. Sections were then reacted with diaminobenzidine/H 2 O 2 in 0.05 M Tris buffer pH 7.6, resulting in a brown reaction product. Incubation with the primary antibody was omitted in control reactions. Immunostaining of placental tissue was performed as a positive control.
In-situ hybridization
The endometrial tissue sections, localized on slides that were sterile and RNase-free, were incubated in phosphatebuffered saline (PBS).
Pre-hybridization: The endogenous phosphates of the tissue were quenched with 5% acetic acid in PBS (0.13 M NaCl, 7 mM Na 2 HPO 4 , 3 mM NaH 2 PO 4 ) for 10 min, followed by incubation for 5 min in 0.5% Triton X-100 in PBS, acetylation for 10 min in 0.25% acetic acid anhydride in 0.1 M Tris-buffered ethanolamine pH 8.0, washing in 1× PBS, dehydration, and air drying. A mixture consisting of 50% formamide, 4× standard saline citrate (SSC; 0.15 M NaCl, 0.015 M sodium citrate pH 7.0) plus 10% dextran sulphate was applied for prehybridization, and the slides were incubated for 1 h at hybridization temperature.
Hybridization: The mixture for hybridization consisted of 50% formamide, 4× SSC, 10% dextran sulphate and digoxygenin (DIG)-labelled oligonucleotide probes (0.1 pmol/µl). The nucleotide probes and complementary sense strand probes for negative controls were synthesized by Dianova, according to the sequence previously published by Jameson et al. (1986) with lengths of 28 and 32 bases, respectively. The probes were labelled using a TdT-tailing reaction using a DIG-dUTP tailing kit (Boehringer Mannheim) and according to the manufacturer's instructions. Hybridization was carried out overnight at 40°C in a moist chamber. Identical conditions were used for hybridization of probes and sense strand probes used as negative controls. After hybridization, the slides were washed three times in 2× SSC at room temperature, twice in 1× SSC for 15 min at room temperature, and once in 1× SSC for 15 min at 40°C.
Immunodetection: To detect DIG-labelled probes, slices were incubated with an anti-DIG alkaline phosphatase conjugate (Boehringer Mannheim) at room temperature for 1 h, after a 30 min preincubation with 5% fetal calf serum, 0.3% Tween 20 in PBS. Blue colour development was achieved with a NTB/BICP solution (Boehringer Mannheim) in 0.1 M NaCl pH 9.5, placed in darkness for about 3 h in a moist chamber.
Studies on isolated endometrial tissue Cell culture, uterine flushing and enzyme immunoassay
Fresh endometrium specimens were obtained on cycle day 21 from normal, healthy subjects aged between 21 and 33 years. All procedures related to prewashing and preparation of tissue specimens or of isolated endometrial stromal and epithelial cells for cultivation were carried out using RPMI 1640 medium containing 2 mM L-glutamine, 50 U/ml penicillin and 50 µg/ml streptomycin (Gibco) according to Martelli et al. (1993) . Endometrial cells were isolated with RPMI 1640 and additives containing 0.15% collagenase B (Boehringer-Mannheim) for 45 min at 37°C. Glandular epithelial and stromal cells were divided by sedimentation under gravity (Laird et al., 1994) . The 24 h cell culture in RPMI 1640 medium with additives was performed under culture conditions of 37°C and a humid, 5% CO 2 /5% O 2 atmosphere. A part of the tissue specimen was prepared for cell lysis by homogenization in a Potter-Elvehjem glass homogenizer using hypotonic lysis conditions of 10 mM phosphate buffer containing 50 U/ml penicillin and 50 µg/ml streptomycin. Jet-washing of the uterine cavity of patients in mid luteal phase was performed by flushing with six discontinuous volume probes of sterile physiological saline (0.9% NaCl), using a modification of the method of Licht et al. (1996) . Hormone concentrations were determined in the flushing fluids and total flushed hormone content was calculated. Hormones were assayed in the culture supernatant, in the endometrium tissue lysate, and in the uterus flushings using a total/β-HCG microparticle enzyme immunoassay (MEIA) (Abbott) and the Enzymun enzyme immunosorbent assay (EIA) for LH, FSH, PRL, oestradiol and progesterone (Boehringer Mannheim). A cross-reactivity of the total/β-HCG test to LH and FSH was not detectable, either at 1000 mU/ml or after adding exogenous gonadotrophins according to Abbott's guide.
Reverse transcription-PCR
The mRNA was extracted from endometrial tissue obtained in the mid-luteal phase of menstruation from patients aged between 20 and 32 years using a diagnostic abrasion procedure. mRNA was obtained using a Quick prep mRNA kit (Pharmacia) with specific binding to oligo dT-cellulose, and stored at -70°C. The mRNA was reverse-transcribed using a standard method of 2.5 µl mRNA, before being heated at 65°C for 5 min, followed by cooling to room temperature, with 7.5 µl of the c-DNA mixture to give a final concentration of 10 mM Tris-HCl pH 8.3, 50 mM KCl, 5 mM MgCl 2 , 1.0 mM each of deoxy (d)ATP, dCTP, dGTP and dTTP, 0.02% gelatine, 25 U/10 µl RNase inhibitor, 15 U/10 µl AMV-Revertase, 0.8 µg/10 µl random dT(15) primer (Boehringer Mannheim), respectively at the oligonucleotide with a β-HCG location of +468/+484 (Bo and Boime, 1992) .
Following a 5 min, 95°C step to destroy the revertase activity, the mixture was incubated for 10 min at 25°C and 60 min at 42° C (all reactions were carried out in the thermal cycler; Perkin-Elmer). In the reverse transcription tube, the PCR procedure continued with a 40 µl PCR mixture of final concentration 10 mM Tris-HCl pH 8.3, 50 mM KCl, 1.5 mM MgCl 2 , 0.2 mM each of dATP, dCTP, dGTP and dTTP, 1.25 U/50 µl Taq-DNA polymerase and 1 µM each of β-HCG primers with location -351/-335, +468/+484 and +191/+211, respectively. The following cycling protocol was used: 1 min at 94°C; 2 min at 64°C; and 3 min at 74°C for 25 cycles (Perkin-Elmer cycler; Bo and Boime, 1992) . Aliquots of 9 µl PCR products were placed on a 1.5% agarose gel to demonstrate the efficiency and fidelity of the β-HCG DNA fragment production, using 0.1% ethidium bromide for UV identification and photographic documentation.
Electrophoresis and immunoblotting
Specimens of about 1 mm 3 in size were taken up into 150 µl 0.1 M PBS containing 1% sodium dodecyl sulphate (SDS), sonicated (2 × 5 min), heated at 100°C for 5 min, and centrifuged. Aliquots of the supernatant (40 µg protein/lane) were electrophoresed on 12% SDSpolyacrylamide gel and blotted onto nitrocellulose membrane using a Bio-Rad apparatus. For blotting analysis, the membrane was blocked with 0.1 M PBS buffer containing 0.1% Tween-20 for 20 min and incubated with the monoclonal antibody at 1:100 dilution for 1 h at room temperature. Two different antisera were used, anti-HCG/β-HCG (clone M 94138) and anti-HCG/β-HCG (clone M 94139.7). Subsequently, the blot was washed three times with blocking buffer and the incubation repeated with a secondary antibody (rabbit anti-mouse, 1:500; Cappel). Visualization was achieved by a horseradish peroxidase-coupled antibody (goat anti-rabbit, 1:1000; Bio-Rad) using 4-chloro-1-naphthol as substrate.
Detection of HCG in cycling human endometruim
To study the presence and distribution of HCG producing cells in the endometrium, we used immunohistochemical and in-situ hybridization techniques. These revealed a cycle-dependent appearance and distribution of HCG structures and its mRNA. In total, 30 tissue specimens were examined (proliferative phase, n = 15; early secretory phase, n = 7; mid luteal phase, n = 5; late luteal phase, n = 3). Chorionic tissue served as positive control ( Figure  1A and B) .
No immunoreactive cells were detectable during the proliferative phase of the endometrium, but in the secretory phase HCG structures were found in the glands, as well as in the stroma. Using the immunohistochemical technique, many HCG granules were observed in glandular cells in the early secretory phase; the granules were located in the basal part of cell, below the nucleus ( Figure 1C) . Scattered HCG-positive cells were also seen in the stroma. In the mid secretory phase, HCG was transported to the apical pole of the glandular epithelium and later released into the lumen of uterine cavity ( Figure 1D ). The greatest number of HCG-positive cells in the stroma were seen in the mid secretory phase ( Figure 1D ), though these decreased in the late secretory phase.
The two oligonucleotides serving as positive probes showed the expected staining of the trophoblast in the positive tissue control ( Figure 1B) . To evaluate the specificity of each probe, they were tested alone, whereby equal staining intensity could be obtained. A negative control hybridization with sense strand oligonucleotides resulted in no staining of either the decidual or endometrial cells. No staining was detectable in tissues during the proliferative phase. The use of an oligonucleotide mix of both probes in endometrium hybridization resulted in an intense staining of endometrial glands in the early phase ( Figure 1D ). Weaker signals were obtained in single cells in stroma. In general, staining of the cyclic endometrial tissue was weaker than in trophoblastic cells. The staining signal disappeared in the following cycle phase ( Figure 1F ).
With RT-PCR, gene expression of β-HCG was identified in the mid secretory endometrium. The amplified c-DNA of the β-HCG genes 3, 5, 7 and 8 were established with different primer pairs, showing 836 bp and 562 bp DNA products (Figure 2A ). Placental tissue was used as the positive control ( Figure 2B ).
Electrophoresis and immunoblotting of endometrial tissue preparations revealed antibody-specific staining patterns. MAB M94139 showed how the complete β-HCG subunit appeared as approximately 31-33 kDa. Two additional peptides were detected at positions 18 kDa and 15 kDa respectively. Figure 3 is representative of a Western blot for endometrial specimens. In extracts of chorionic tissue used as a positive control, the band of the complete β-HCG subunit appeared at ∼ 35 kDa. In addition, the peptide band at 18 kDa was obvious, but not that at 15 kDa (Figure 3 ). Differential, hormonal activity of endometrial tissue was determined by quantitative immunoassays. Data revealed a high capacity of the tissue to produce HCG, FSH and progesterone, whereas production of LH, PRL and oestrogen was low (Figures 4 and 5) . HCG showed the highest hormone activity per gram tissue. Hormone activity was identified in the supernatant, while the pellet exhibited only a weak activity. Cell separation by collagenase dispersion and centrifugation was carried out to determine the source of HCG activity (Figure 6 ). Both glandular and stromal cell fractions showed the ability to produce HCG activity. Separation resulted in a reduction in Figure 2 . Demonstration of β-HCG 3, 5, 7 and 8 gene transcripts in human endometrium of mid luteal phase of the fertile cycle. The mRNA, extracted from endometrial and placental tissue and purified using an oligo (dT)30-cellulose procedure, was reverse-transcribed under standard conditions, the β-HCG using an oligo p (dT)15-primer and, respectively, the β-HCG oligonucleotide located at position +468/+484. (Modified from Bo and Boime, 1992) . Endometrium-and placenta-derived c-DANN products were amplified by primer pairs of position +468/+484 and (A) position -351/-335 for genes 3, 5, 7 and 8 transcripts of β-HCG resulting 836 bp band in rising mRNA doses as well as (B) position -332/-316 for the gene 7 transcript with 816 bp band PCR products. The placenta transcripts were used as a positive control of the correct amplification conditions. The thermocycling programme chosen was 1 min × 94°C, 2 min × 64°C and 3 min × 74°C for 25 cycles. The figure shows that β-HCG is derived in luteal phase endometrial tissue. hormonal tissue activity to about 30% for similar amounts of tissue.
Function of endothelial HCG secretion
The results of the present study showed that the secretory endometrium is able to produce and secrete HCG. The proliferation of the endometrium is determined by the presence of oestrogens, whereas the secretory phase results from the presence of both progesterone and oestrogens. HCG was detected by neither immunohistochemical nor in-situ hybridization investigations during the proliferative phase.
HCG, the production of which was observed with the onset of the luteal phase, is localized in the early secretory phase to the basal cell compartment. However, in the mid luteal phase, a transfer to the apical cell area occurred, followed by secretion into the lumen of the glands. Thus, the secretory changes of the endometrium and HCG production appear to be progesterone-induced processes. Nisula and Bartocci (1984) Chemoattractant for mononuclear cells Reinisch et al. (1994) Increase in lymphocyte trafficking Otsuki et al. (1990) Autocrine/paracrine a Differentiation of trophoblast and implantation Hearn (1986) Attachment of the embryo Hearn (1986) Endocrine Maintenance of the corpus luteum Hanson et al. (1971) Growth factor for embryo and decidua Lapthorn et al. (1994) Vasodilatation Hermsteiner et al. (1997) a β-HCG may function in an autocrine and paracrine fashion as it was reported that the endometrium possesses HCG receptors (Reshef et al., 1990) .
As the localization of HCG (assessed immunohistochemically) may not be identical to its site of synthesis, we performed in-situ hybridization studies to identify the production site. The results revealed a distribution pattern in positive control tissues as reported previously. Characteristically, the syncytiotrophoblast contained much more HCG than the cytotrophoblast (Kurman et al., 1984) . The data were supported by Western blot analysis using monoclonal antibodies which detected the β-HCG subunit, without significant cross-reactivity with LH. β-HCG appeared in the expected molecular weight position. Interestingly, in addition to the 18 kDa peptide, another peptide of lower molecular weight was detected in both the endometrium and placenta, though this was regarded as a peptide fragment of β-HCG. Moreover, by using RT-PCR we detected gene expression in the endometrium.
Radioimmunoassay investigations of the uterine jet wash fluid in the secretory phase revealed the presence of HCG, though clearly HCG both in tissue cultures and jet washings may have been of exogenous origin. It is known that HCG is present in seminal plasma (Brotherton, 1989) , but the existence of an artefact was excluded on the basis that the women in our study had not had intercourse hormone (Nisula and Bartocci, 1984) , though its immunological action remains under investigation. HCG is the proven luteotrophic hormone, though endometrial HCG may be responsible for the maintenance of corpus luteum function in early pregnancy (Hanson et al., 1971) (Table 1) .
Although HCG has long been regarded as a characteristic hormone of pregnancy, reports have been made on its occurrence in epithelial tissues (Braunstein et al., 1979) ; hence, the occurrence of β-HCG in endometrium is not surprising. In addition, HCG has also been detected in many epithelial tumours (Marcillac et al., 1992) , as well as in mononuclear cells (Harbour-McMenamin et al., 1986) . Positive-stained cells in the stroma may be mononuclear cells with an immunoreactive HCG. Interestingly, HCG may be characterized as a chemoattractant for mononuclear cells (Reinisch et al., 1994) , which are necessary for implantation and for immunotolerance of the pregnancy. Both the endometrium and corpus luteum contain significant numbers of macrophages and lymphocytes, particularly during the luteal phase. Natural killer cells increase in number in the endometrium during the late secretory phase and early pregnancy. Endometrial HCG is perhaps an important factor in attracting mononuclear cells into the endometrium (Reinisch et al., 1994) , in order to protect the embryo during implantation. Because HCG improves lymphocyte trafficking (Otsuki et al., 1990) , it is possible that there is an amplified motion of mononuclear cells from the uterus to the ovary via the lymph vessels. The secretory endometrium and its products have been analysed in numerous studies (e.g. Seppälä et al., 1992) , the feature of the secretory endometrium being glycogen. However, the function of the glycogen is not yet understood, as it displays the same pattern in cell compartments during the luteal phase as does HCG. At first, glycogen is detected on the cell base and later is secreted into the lumen. Because HCG comprises 30% glycogen (Birken, 1984) , it may be feasible to investigate the nature of other glycoproteins, oligosaccharides and HCG with glycogen staining, and with the phenol red reaction. Until now, it has been assumed that the glycogen nourishes the embryo during implantation, though in our opinion this explanation is highly doubtful. Many glycoproteins (hormones, cytokines and growth factors) are produced in the secretory endometrium (Navot et al., 1991) . Lapthorm et al. (1994) showed that the threedimensional structure of β-HCG is similar to that of certain protein growth factors, including PDGF-β, TGF-β and NGF. During implantation, paracrine growth factors are required; previously, Hearn (1986) suspected that HCG might be essential at the local level for trophoblastic differentiation and implantation.
Ovarian blood flow is highest during the luteal phase, while marked uterine blood flow is seen during the secretory phase. Luteal maintenance may be mediated by local vascular transport of luteotrophic or anti-luteolytic substances from the gravid uterus to the ovary. Some authors reported the existence of a counter-current exchange mechanism between blood vessels of the human uterine adnexae. Labelled progesterone, when infused into the uterine cavity, was detected in the ovary after a short time. Samples infused in the uterine vein were also found rapidly in the ipsilateral ovary, transfer having occurred via a local arteriovenous route (Halket et al., 1985; Bendz et al., 1979; Einer Jensen et al., 1989) . During the secretory phase, the endometrial HCG could quickly reach and support the corpus luteum via this counter-current exchange. A transient increase in uterine blood flow occurs concomitantly with the maternal recognition of pregnancy. This increase in uterine blood flow follows embryonal attachment and occurs simultaneously with an increase in ovarian blood flow. Ovarian blood flow may hence facilitate the increased transport of conceptus-related luteotrophic and/or anti-luteolytic substances from the gravid uterus to the corpus luteum-bearing ovary (Mapletoft et al., 1976; Del Campo et al., 1980) . In support of this hypothesis, it is known that progesterone concentrations in the peripheral blood are elevated at the time of maternal recognition of pregnancy, and that this is associated also with an increased concentration in the uterine blood (Reynolds et al., 1984) . Thus, ovarian vasodilatation may prevent luteolysis by maintaining luteal blood flow and thereby luteal morphology and function. HCG itself seems to induce vasodilatation (Hermsteiner et al., 1997) , thereby improving the flow of uterine fluid.
The corpus luteum is rich in lymph vessels (Morris and Sass, 1966) which, in the endometrium during the luteal phase, grow towards the endometrial glandular epithelium. This strong lymphatic vasculature pulls from the fundus uterus to the ovary, and then along the ovary into the para-aortic lymph nodes. It seems that in this cyclic phase, both morphological and functional changes occur under the control of progesterone (Reiffenstuhl, 1957) .
Luteal maintenance soon after conception depends on chorionic gonadotrophic stimulation. During implantation, the immediate initial vascularization caused by growth factors could allow upstream endometrial HCG to maintain the corpus luteum as its most important task, that is, to support early pregnancy.
Thus, we postulate that endometrial HCG is transported via lymphatic and blood vessels to reach the corpus luteum during implantation and early pregnancy. This gland is then stimulated to produce more progesterone for establishing implantation and maintaining early pregnancy. Serum HCG is first detected at 7 days after ovulation, which is regarded as the time of onset of implantation. It cannot be excluded, however, that early serum concentrations of HCG are of endometrial origin. The upstream flow of uterine fluid via blood and lymphatic vessels is probably insignificant on a quantitative basis during the luteal phase, but is greatly increased at the time of implantation.
In the early implantation phase, greater quantities of HCG rapidly reach the circulation, a situation which could be regarded as an inflammatory change with a reinforced vascularization. Therefore, the first HCG demonstrated in the peripheral blood is very likely to be of endometrial origin. Endometrial HCG secretion could explain the very early rise in serum HCG because this very early and high hormone concentration alone could not be explained by the minute cell mass of the blastocyst.
It is known that preimplantation human embryos secrete HCG (Fishel et al., 1984) . Hearn (1986) suggested that HCG was essential at a local level for trophoblastic differentiation and implantation because the incubation of hatched embryos with β-HCG subunit antibody blocked embryo attachment and induced lysis of the embryos within 2 days. HCG passes via the existing lymphatic vessels to the corpus luteum, where it causes the rise in progesterone concentrations seen very early in conception, but not in non-conceptional cycles (Lenton et al., 1982) .
In early pregnancy, HCG appears to be a most important substance. The nature of the recent work hereby salutes the principle of redundancy. Endometrium, embryo and mononuclear cells each secrete β-HCG to rescue the corpus luteum and to enable the embryo to be tolerated.
In conclusion, HCG secreted by glandular epithelium during the progesterone-induced secretory phase could be an important exocrine, endocrine, autocrine and paracrine factor, its main action being perhaps to utilize the existing utero-ovarian interrelationships to rescue the corpus luteum during early pregnancy. However, further investigations are required to define the regulation and function of HCG in endometrial physiology and pathophysiology.
